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http:WHAT THIS PAPER ADDS
The mean AVVQ score was found to be 10 points higher in patients with bilateral than with unilateral disease.
The distribution of veins (unilateral vs. bilateral) must be adjusted for when reporting AVVQ scores.Objectives: It has been suggested that the Aberdeen Varicose Vein Questionnaire (AVVQ) could be used to help
inform a patient pathway for referral and treatment of varicose veins. We aimed to determine 1) which patient
and vein characteristics affected the AVVQ score, and 2) whether scores differed between those who were and
were not offered treatment.
Methods: Patients completed the AVVQ at the clinic prior to being seen. Treatment was offered to patients with
symptoms, and duplex detected truncal incompetence by surgeons blinded to the score.
Results: A total of 228 consecutive patients completed the AVVQ: 199 were valid questionnaires. On multivariate
analysis, factors associated with a worse quality of life were female gender (p ¼ .034, 3.14 mean unit increase in
AVVQ), and bilateral varicose veins (10.25 unit increase, p < .001). For patients with C2 disease, only the
presence of bilateral veins was signiﬁcant. Overall, the AVVQ score was higher in those patients offered
treatment than in those who were not (mean 20.3 [SD ¼ 9.9] vs. 17.3 [SD ¼ 10.3], p ¼ .023), which equates to a
2.74 unit increase. This was not signiﬁcant in patients with C2 disease.
Conclusion: It is unlikely that a threshold AVVQ score could be used to aid referral of patients with C2 disease.
The distribution of veins (unilateral vs. bilateral) must be adjusted for when reporting AVVQ scores.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 22 May 2013, Accepted 31 August 2013, Available online 7 September 2013
Keywords: Aberdeen Varicose Vein Questionnaire, Gender, CEAP, Endovenous, BilateralINTRODUCTION
Treatment of varicose veins results in a considerable
workload and ﬁnancial burden to the NHS. Visible varicose
veins occur in up to 40% of men and 32% of women, and
many patients have impaired quality of life. Treatment of
varicose veins has been shown to improve patients quality
of life for at least 1 year.1e7 A randomized controlled trial
(RCT) of surgery versus conservative management esti-
mated that the incremental cost per quality-adjusted life
year (QALY) for surgery was £4682, with a 70% probability
that the cost per QALY would be less than the National
Institute for Clinical Excellence (NICE) £20,000 threshold.8
Endovenous treatments have been shown to improve
quality of life and are likely to be more cost-effective than
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//dx.doi.org/10.1016/j.ejvs.2013.08.019Patient-related outcome measures (PROMs) are increas-
ingly used to assess the quality of services provided across
the NHS and inform service redesign. From 2009, the
Standard NHS Contract for Acute Services in England re-
quires all licensed providers of NHS-funded varicose vein
treatment to ask patients to complete PROM question-
naires (before and after surgery). The Aberdeen Varicose
Vein Questionnaire (AVVQ) is used as the disease-speciﬁc
PROM for varicose vein interventions. Data have shown
that treatment of varicose veins results in signiﬁcant
improvement in health for patients, with an almost a
halving of the AVVQ score compared to preoperative
values.9 Furthermore, patients with the lowest (less severe)
pre-treatment scores have been found to beneﬁt least from
intervention.
It has been suggested that the AVVQ should be used to
help inform a patient pathway for referral and treatment of
varicose veins.10,11 With the increasing use of the AVVQ, it
is important to determine which patient factors may inﬂu-
ence the score and also importantly if there should be a cut-
off value to determine which patients should be offered
interventional treatment.
Table 1. AVVQ score, patient and vein characteristics.
Characteristics AVVQ score p
n Mean SD
Gender Female 142 20.1 9.6 .007
Male 57 16.9 11.0
Recurrence Primary 152 18.8 9.2 .696
Recurrent
varicose veins
47 20.6 12.5
Location of
varicose vein
Unilateral 133 15.9 7.7 <.001
Bilateral 66 25.9 11.0
Symptoms Symptomatic 175 19.8 10.2 0.015
Asymptomatic 24 14.7 8.2
Reﬂux Truncal reﬂux 150 20.1 10.3 .023
No truncal reﬂux 49 16.4 9.1
C grade 0 8 11.1 4.8 .072
1 9 17.3 5.1
2 145 19.3 9.3
3 6 24.1 16.1
>4 31 19.2 10.1
Note. n is the number of patients in each category. Values for p
obtained using non-parametric (ManneWhitney U and Kruskale
Wallis) tests as appropriate. AVVQ ¼ Aberdeen Varicose Vein
Questionnaire.
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if any, between the AVVQ scores in patients referred to an
open access secondary care varicose vein clinic and gender,
clinical grade in the Clinical, Etiologic, Anatomic, Patho-
physiological (C) classiﬁcation and other vein characteristics
(primary vs. recurrent; unilateral vs. bilateral; symptomatic
vs. asymptomatic; main stem incompetence vs. no main
stem incompetence). The unit’s policy was to offer patients
with symptomatic varicose veins and duplex-detected
truncal reﬂux endovenous treatment when possible. Addi-
tionally, we aimed to determine if the AVVQ score in pa-
tients who fulﬁlled the unit’s criteria for endovenous
treatment was different from those patients who did not.
PATIENTS AND METHODS
A total of 228 consecutive patients who were referred to
the open access varicose vein clinic completed the AVVQ at
the clinic prior to the appointment with a vascular surgeon
(between June and end of October 2012). The local referral
policies allowed for all patients with symptomatic varicose
veins to be referred for consideration of treatment in
accordance with the NICE referral guidelines. The ﬁve
consultant specialist were blinded to the score. Reﬂux was
deﬁned as the presence of greater than 1-second truncal
reﬂux. Patients with learning difﬁculties or those who
required an interpreter were excluded.AVVQ
The AVVQs were scored using the method described and
validated by Andrew Garratt.12,13 The total score for the 13
questions ranges from 0 to 100 points, with 0 points indi-
cating the best possible quality of life.Missing data
Questionnaires in which question 1 or fewer than nine
questions were completed were excluded. For patients with
unilateral veins, if a patient consistently omitted questions
relating to their unaffected leg then the missing answers
were assumed to be no/none at all. In all other cases, for
omitted questions a negative coefﬁcient was used to
distinguish between answers ‘no’ or ‘none at all’. Negative
coefﬁcients were summated and their overall value sub-
tracted from the maximum points that can be scored in the
AVVQ.Statistical analysis
Validated AVVQ scores were subsequently analysed with
regard to gender, C grade; primary/recurrent; unilateral/
bilateral; symptomatic/asymptomatic; main stem incompe-
tence/no main stem incompetence; and whether treatment
offered/no treatment offered by a fully trained statistician.
SPSS version 20 was used in data analyses. Normality of the
data was assessed using graphical methods, including fre-
quency distribution on a histogram and normal QeQ plot.
The KolmogoroveSmirnov test was used as a conﬁrmation.
The ManneWhitney U test was used in the preliminaryanalysis to determine whether the differences observed
were statistically signiﬁcant as our outcome data: AVVQ
have non-normal distribution. The KruskaleWallis test was
utilized to compare AVVQ scores in a different C grade. The
signiﬁcant variables from univariate analyses were entered
in multiple regression analysis to predict AVVQ from iden-
tiﬁed signiﬁcant independent variables. All probability tests
were two-sided and statistical signiﬁcance was at p < .05.
RESULTS
A total of 199 out of 228 AVVQs were valid questionnaires.
Twenty-seven questionnaires were excluded as the patients
did not draw in the presence of varicose veins in question 1,
and in a further two questionnaires fewer than nine ques-
tions were answered. These patients were excluded from
the analysis. The mean (range) age was 49 years (20e86
years), the male to female ratio was 1:2.5, and the mean
(standard deviation, SD) AVVQ score for the patients as a
whole was 19.2 (SD 10.1) (Table 1). Of note, 17 patients did
not have varicose veins (CO/C1) and 24 were either
completely asymptomatic or had symptoms which the
specialist did not feel were attributed to their varicose
veins.Factors affecting the quality of life in patients with
varicose veins
The majority of patients had a C2 (Table 1); only two pa-
tients had a higher C grade classiﬁcation than 4 (C5, n ¼ 1;
C6 n ¼ 1). The AVVQ scores increased in C3 compared with
C2, but were similar in C2 and C4 (Table 2). Overall, there
was no association between the C grade and the AVVQ
score.
On univariate analysis, quality of life was lower in pa-
tients presenting with symptomatic than asymptomatic
Table 2. Multivariate regression: Aberdeen Varicose Vein
Questionnaire score as the dependent variable.
Coefﬁcients 95% CI p
b Standard
error
Lower
bound
Upper
bound
Recurrent
varicose veins
0.29 1.54 3.32 2.74 .849
Bilateral
varicose veins
10.25 1.36 7.56 12.94 <.001
Symptomatic 4.28 3.25 2.13 10.70 .190
Reﬂux 3.99 2.75 1.44 9.42 .149
Female sex 3.14 1.47 0.24 6.03 .034
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veins had a worse quality of life than those with unilateral
varicose veins (p < .001). Female gender was associated
with a worse quality of life (p ¼ .007). Varicose veins
associated with truncal reﬂux (great or small saphenous)
had a greater impact on the quality of life than varicose
veins not associated with truncal reﬂux (p ¼ .023). No
signiﬁcant difference was found between AVVQ scores in
patients presenting with primary and recurrent varicose
veins (p > 0.05) (Table 1). Patients who had symptomatic
varicose veins and main truncal reﬂux and were offered
treatment had a higher mean (SD) AVVQ score than the
patients who were not offered any surgical intervention
20.3 (9.9) versus 17.3 (10.3) years (p ¼ .023).
On multiple regression analysis female gender and the
presence of bilateral varicose veins remained independent
factors that predicted the quality of life in patients with
varicose veins (Table 2). The presence of recurrent varicose
veins, symptomatic varicose veins and truncal reﬂux were
not found to be independent factors that could predict the
quality of life (Table 2).C2
The multivariate analysis was repeated for patients with C2
varicose veins, who made up 73% of the cohort. In this
analysis female gender was not signiﬁcant but the presence
of bilateral veins remained signiﬁcant (Table 3). The mean
AVVQ score in the patients who were offered treatment
(n ¼ 96) was 20.1 (SD 8.7) and those were not offered
treatment (n ¼ 49) 17.8 (SD ¼ 10.2, p ¼ .1).Table 3. Multivariate regression in the subset of people with CEAP
grade 2.
Coefﬁcients 95% CI p
b Standard
error
Lower
bound
Upper
bound
Recurrent
varicose veins
0.95 1.64 4.19 2.28 .561
Bilateral
varicose veins
8.90 1.51 5.92 11.88 <.001
Symptomatic 2.73 3.94 5.06 10.52 .489
Reﬂux 3.29 3.17 2.96 9.55 .300
Female sex 2.33 1.62 0.87 5.53 .153DISCUSSION
The main ﬁndings of this study is that the AVVQ score was
found to be higher in females and in patients with bilateral
veins than with unilateral veins. These factors were inde-
pendently associated with impaired quality of life. Patients
who had symptomatic veins and reﬂux on duplex scanning
were offered intervention with endovenous treatment. The
patients who were offered intervention were found to have
a signiﬁcantly poorer quality of life than those who were
not.
For the entire cohort, females had a poorer quality of life
with a mean increase in AVVQ score of 3.14 units compared
with males. However, when patients with C2 were analysed
separately no affect for gender on the AVVQ was observed.
This is in contrast to the study by Conway et al.,10 who
found that women with C2 and C3 varicose veins have
signiﬁcantly worse quality of life as assessed by the AVVQ
than men with similar C grade disease but this was not
evident in patients with more severe disease (C4e6).
A novel ﬁnding from this series is the inﬂuence of
whether the veins were unilateral or bilateral on the AVVQ
score. There was a mean increase of 10.25 units in the
AVVQ score in patients who presented with bilateral vari-
cose veins compared with unilateral veins. This has not
previously been documented and the beneﬁt of treatment
especially on the AVVQ score if performed only unilaterally
or as a staged procedure is not known. It is interesting that
despite the surgeons being blinded to the AVVQ score,
those patients they offered treatment to had a signiﬁcantly
higher AVVQ score than those who were treated conser-
vatively. This lends support to the proposal for a threshold
to guide referral for treatment of varicose veins, especially
when the improvement following treatment has been
shown to be greatest in those with the worst quality of life.9
However, it can be seen that there was a considerable
overlap in the range of AVVQ score in those who were and
were not offered treatment. Furthermore, an analysis of
patients with C2 score showed a non-signiﬁcant increase in
the AVVQ score in those who were offered compared to
who were not offered treatment. This is probably because
treatment was more likely to be offered to patients with
more severe disease. These are important ﬁndings which
need to be considered if the AVVQ is to be used to assess
the quality of services provided across the NHS and inform
service redesign. It is also of note that in this study, 11% of
questionnaires had to be excluded as they were not
appropriately completed by the patient.
In this study, a number of other factors, such as presence
of symptoms, recurrent veins and presence of reﬂux were
signiﬁcant on univariate but not multivariate analysis. Pre-
viously, only weak correlations have been noted between
the AVVQ and anatomical reﬂux.15 Similarly, Conway et al.10
found no associations between the AVVQ and symptoms.
Patients may feel that in the current economic climate that
they would not be offered treatment for cosmetic reasons
and thus the presence or absence of symptoms may be
inﬂuenced by other factors. We did not ﬁnd any statistical
718 A. Staniszewska et al.difference between the C-grade and AVVQ. However, it can
be seen that the score was higher in C3 than C2 but not in
C4. Our ﬁndings are in contrast to two previous studies
which showed a correlation between the AVVQ and the
clinical grading of varicose veins as assessed by the C
grade.11,14
CONCLUSIONS
The AVVQ was not higher in patients with C2 disease who
were offered intervention than in those who were not. It is
unlikely that a threshold could be used to aid referral of
patients with C2 disease. The distribution of veins (unilat-
eral vs. bilateral) must be adjusted for when reporting
AVVQ scores.
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